GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Easton Pharmaceuticals Inc (OTCPK:EAPH) » Definitions » Operating Cash Flow per Share

EAPH (Easton Pharmaceuticals) Operating Cash Flow per Share : $0.00 (TTM As of Sep. 2021)


View and export this data going back to . Start your Free Trial

What is Easton Pharmaceuticals Operating Cash Flow per Share?

Easton Pharmaceuticals's operating cash flow per share for the three months ended in Sep. 2021 was $0.00. Easton Pharmaceuticals's operating cash flow per share for the trailing twelve months (TTM) ended in Sep. 2021 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Easton Pharmaceuticals's Operating Cash Flow per Share or its related term are showing as below:

EAPH's 3-Year OCF Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 6.4
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Easton Pharmaceuticals Operating Cash Flow per Share Historical Data

The historical data trend for Easton Pharmaceuticals's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Easton Pharmaceuticals Operating Cash Flow per Share Chart

Easton Pharmaceuticals Annual Data
Trend Dec01 Dec02 Dec03 Dec04 Dec18 Dec19 Dec20
Operating Cash Flow per Share
Get a 7-Day Free Trial -63.82 -93.12 - - -

Easton Pharmaceuticals Quarterly Data
Jun02 Sep02 Dec02 Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec18 Dec19 Dec20 Mar21 Jun21 Sep21
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Easton Pharmaceuticals's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Easton Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Easton Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Easton Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Easton Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.



Easton Pharmaceuticals Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Easton Pharmaceuticals's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2020 is calculated as

Operating Cash Flow per Share (A: Dec. 2020 )=Cash Flow from Operations (A: Dec. 2020 )/Shares Outstanding (Diluted Average) (A: Dec. 2020 )
=-0.189/1344.932
=-0.00

Easton Pharmaceuticals's Operating Cash Flow per Share for the quarter that ended in Dec. 2020 is calculated as

Operating Cash Flow per Share (Q: Sep. 2021 )=Cash Flow from Operations (Q: Sep. 2021 )/Shares Outstanding (Diluted Average) (Q: Sep. 2021 )
=-0.059/1344.932
=-0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Easton Pharmaceuticals Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Easton Pharmaceuticals's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Easton Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
2 Bloor Street East, Suite 3500, Toronto, ON, CAN, M4W 1A8
Easton Pharmaceuticals Inc is a diversified specialty pharmaceutical company. It owns and develops proprietary transdermal delivery technology and therapeutic over the counter products and drugs to treat cancer and other diseases. The company also owns exclusive distribution rights in Mexico and Latin America for patented women's diagnostic and preventative care products. It is focused on the development of product Viorra. The firm's products include Nauseasol, Skin Renou HA, Kenestrin gel, and XILIVE, among others.

Easton Pharmaceuticals Headlines

From GuruFocus